The resurgence of interest in Boron Neutron Capture Therapy (BNCT) as a treatment for malignant lesions has resulted in the synthesis of numerous boron compounds as candidates for clinical use. BNCT is a selective radiotherapy using boron-10 which absorbs thermal neutrons and releases high Linear Energy Transfer (LET) alpha particles by 10 B (n, α) 7 Li reaction. The alpha radiation kills cells in the range of 5-9 µm from the site of the α generation. Therefore, it is theoretically possible to kill tumor cells without affecting adjacent healthy tissues, if 10 B-compounds could be selectively deliv- . They have a well know brain distribution, so these compounds, labeled with 10 B are potential agents for BNCT. A general synthetic method has been developed for the rapid and efficient production of boronated Harmine.
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Results And Discussion

Iodination
The methods for iodination have been used previously for indolealkylamine [4] and phenethylamines [4] using thallium trifluoroacetate as specific oxidizing agent of molecular iodine for iodination of aromatic compounds [5] .
Boronation
We used the condensation of the Grignard reagent from 8-I-Harmine with trimethylborate. This method was previously used [6] for preparation of phenol from phenylbromide and trimethylborate with formation of phenylboronic acid as intermediate and for preparation of boronic analogue of cho-line [7] . An alternative synthesis previously used for preparation of boronic analogues of nucleosides and nucleic bases [8] [9] [10] [11] consist in treating the halogenated substrate with n-buthyllithium in THF followed by addition of trimethylborate at -86 o C. Trimethylborate was prepared by standard procedures [12] from 95% 10 B-enriched or natural isotope abundance boric acid and methanol and recovered from the formed azeotrope.
Summary and Conclusions
We have described a method for preparation of 
